SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Centocor ( CNTO )
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
965 13 0 CNTO
Emcee:  PawPr Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
315 Melissa >>I was under the impression that cancer is something that "Pancho Villa-11/11/1997
314 Todd, >>Centocor Inc. officials tried to calm nervous investors by rebuttPancho Villa-11/11/1997
313 <<I am a bit surprised that Cnto's CEO stooped to a level of name calDonaldm-11/11/1997
312 Bruce>>and some of them had received significant immunosuppressive therapPancho Villa-11/11/1997
311 I think "Rogue" was being nice. These analysts are far too problematithebeach-11/11/1997
310 I am a bit surprised that Cnto's CEO stooped to a level of name calling thirebecca-11/11/1997
309 <<Thanks Giuseppe, so 1% of patients developed lymphoma in the 26 weeks AMelissa McAuliffe-11/11/1997
308 Centocor Refutes Claim Drug Increases Rate of Lymphoma Dow Jones Newswires Todd D. Wiener-11/11/1997
307 I'm sorry Sam...make that 4 out of 600 and if I recall correcly it was in tGiuseppe Scalamogna-11/11/1997
306 These patients all had relatively severe rheumatoid arthritis ( which, like othPawPr-11/11/1997
305 How timely. I doubled my position today at $41. Thank you, Merrill Lynch. ToTodd D. Wiener-11/11/1997
304 From Briefing.com: <i>CENTOCOR INC (CNTO) 42 1/2 -5/8. An overreaction! Janice Shell-11/11/1997
303 Thanks Giuseppe, so 1% of patients developed lymphoma in the 26 weeks Avakine sshdu-11/11/1997
302 4 out of 400 patients developed lymphoma in the Avakine study. Although this isGiuseppe Scalamogna-11/11/1997
301 Does anyone on this thread know and care to share information about the number shdu-11/11/1997
300 TideGlider & tutti (ALL!): CNTO's CEO David Hoveck just did a super joFNS-11/11/1997
299 watched ceo take down the merril analyst for misreporting the the drug and erroraymond marcotte-11/11/1997
298nh.ultranet.com!.wavTideGlider-11/11/1997
297 AARON: re: >> couldn't believe the devastation today either but likFNS-11/10/1997
296 Thanks Pancho! BruceTideGlider-11/10/1997
295 Bruce, Growth companies will always attract momentum investors. The strategy Pancho Villa-11/10/1997
294 I believe it is a serious company. How opportunistic that the traders bought inTideGlider-11/10/1997
293 AARON: >>If my memory serves me correctly, along with the downgrade came Pancho Villa-11/10/1997
292 Aaron, Regarding some of the analyst comments, like "...looking for the coThean-11/10/1997
291 Pancho: If my memory serves me correctly, along with the downgrade came a statAARON DIDICH-11/10/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News